Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy

Author: Albertini Veronica   Jain Aklank   Vignati Sara   Napoli Sara   Rinaldi Andrea   Kwee Ivo   Nur-e-Alam Mohammad   Bergant Julia   Bertoni Francesco   Carbone Giuseppina M.   Rohr Jürgen   Catapano Carlo V.  

Publisher: Oxford University Press

ISSN: 1362-4962

Source: Nucleic Acids Research, Vol.34, Iss.6, 2006-01, pp. : 1721-1734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract